PG102 Upregulates IL-37 through p38, ERK, and Smad3 Pathways in HaCaT Keratinocytes

IL-37 is an immunomodulatory cytokine that suppresses inflammation in various cell types and disease models. However, its role in keratinocytes has not been clearly understood, and there has been no report on the agents that can increase the expression of IL-37 in keratinocytes. In this study, we in...

Full description

Saved in:
Bibliographic Details
Main Authors: Hyun-keun Kim, Seonung Lim, Min-Jung Bae, Wonwoo Lee, Sunyoung Kim
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2019/6085801
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547554314682368
author Hyun-keun Kim
Seonung Lim
Min-Jung Bae
Wonwoo Lee
Sunyoung Kim
author_facet Hyun-keun Kim
Seonung Lim
Min-Jung Bae
Wonwoo Lee
Sunyoung Kim
author_sort Hyun-keun Kim
collection DOAJ
description IL-37 is an immunomodulatory cytokine that suppresses inflammation in various cell types and disease models. However, its role in keratinocytes has not been clearly understood, and there has been no report on the agents that can increase the expression of IL-37 in keratinocytes. In this study, we investigated the effects of silencing IL37 in HaCaT keratinocytes and the molecular mechanisms involved in the upregulation of IL-37 by PG102, a water-soluble extract from Actinidia arguta. It was found that knockdown of IL37 resulted in the augmented expression of antimicrobial peptides (AMPs) in response to cytokine stimulation. PG102 increased the expression of IL-37 at both mRNA and protein levels presumably by enhancing the phosphorylation of Smad3, ERK, and p38. Indeed, when cells were treated with specific inhibitors for these signaling molecules, the expression level of IL-37 was reduced. PG102 also promoted colocalization of phospho-Smad3 and IL-37. Our results suggest that IL-37 inhibits the expression of AMPs and that PG102 upregulates IL-37 through p38, ERK, and Smad3 pathways in HaCaT cells.
format Article
id doaj-art-1d155b3ef2b94ece9b45e9035947a425
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-1d155b3ef2b94ece9b45e9035947a4252025-02-03T06:44:17ZengWileyMediators of Inflammation0962-93511466-18612019-01-01201910.1155/2019/60858016085801PG102 Upregulates IL-37 through p38, ERK, and Smad3 Pathways in HaCaT KeratinocytesHyun-keun Kim0Seonung Lim1Min-Jung Bae2Wonwoo Lee3Sunyoung Kim4School of Biological Sciences, Seoul National University, Seoul 151-742, Republic of KoreaSchool of Biological Sciences, Seoul National University, Seoul 151-742, Republic of KoreaViroMed Co. Ltd., Building 203, Seoul National University, Seoul 151-742, Republic of KoreaViroMed Co. Ltd., Building 203, Seoul National University, Seoul 151-742, Republic of KoreaViroMed Co. Ltd., Building 203, Seoul National University, Seoul 151-742, Republic of KoreaIL-37 is an immunomodulatory cytokine that suppresses inflammation in various cell types and disease models. However, its role in keratinocytes has not been clearly understood, and there has been no report on the agents that can increase the expression of IL-37 in keratinocytes. In this study, we investigated the effects of silencing IL37 in HaCaT keratinocytes and the molecular mechanisms involved in the upregulation of IL-37 by PG102, a water-soluble extract from Actinidia arguta. It was found that knockdown of IL37 resulted in the augmented expression of antimicrobial peptides (AMPs) in response to cytokine stimulation. PG102 increased the expression of IL-37 at both mRNA and protein levels presumably by enhancing the phosphorylation of Smad3, ERK, and p38. Indeed, when cells were treated with specific inhibitors for these signaling molecules, the expression level of IL-37 was reduced. PG102 also promoted colocalization of phospho-Smad3 and IL-37. Our results suggest that IL-37 inhibits the expression of AMPs and that PG102 upregulates IL-37 through p38, ERK, and Smad3 pathways in HaCaT cells.http://dx.doi.org/10.1155/2019/6085801
spellingShingle Hyun-keun Kim
Seonung Lim
Min-Jung Bae
Wonwoo Lee
Sunyoung Kim
PG102 Upregulates IL-37 through p38, ERK, and Smad3 Pathways in HaCaT Keratinocytes
Mediators of Inflammation
title PG102 Upregulates IL-37 through p38, ERK, and Smad3 Pathways in HaCaT Keratinocytes
title_full PG102 Upregulates IL-37 through p38, ERK, and Smad3 Pathways in HaCaT Keratinocytes
title_fullStr PG102 Upregulates IL-37 through p38, ERK, and Smad3 Pathways in HaCaT Keratinocytes
title_full_unstemmed PG102 Upregulates IL-37 through p38, ERK, and Smad3 Pathways in HaCaT Keratinocytes
title_short PG102 Upregulates IL-37 through p38, ERK, and Smad3 Pathways in HaCaT Keratinocytes
title_sort pg102 upregulates il 37 through p38 erk and smad3 pathways in hacat keratinocytes
url http://dx.doi.org/10.1155/2019/6085801
work_keys_str_mv AT hyunkeunkim pg102upregulatesil37throughp38erkandsmad3pathwaysinhacatkeratinocytes
AT seonunglim pg102upregulatesil37throughp38erkandsmad3pathwaysinhacatkeratinocytes
AT minjungbae pg102upregulatesil37throughp38erkandsmad3pathwaysinhacatkeratinocytes
AT wonwoolee pg102upregulatesil37throughp38erkandsmad3pathwaysinhacatkeratinocytes
AT sunyoungkim pg102upregulatesil37throughp38erkandsmad3pathwaysinhacatkeratinocytes